Sandbox:Mitra3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{familytree/start |summary=Sample 6}} | {{familytree/start |summary=Sample 6}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[RVMI]]'''| | | |}} | {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[RVMI]]'''| | | |}} | ||
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | || | |!| | | | | | | | | | | | | | |}} | ||
{{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | {{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | ||
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01='''Reperfusion'''|B02='''Maintenance of RV preload'''|B03='''Decreased RV afterload'''|B04='''Restoring Rate/Rhythm and AV synchrony'''|B05='''Inotropic support'''|B06='''Mechanical Circulatory Support'''}} | {{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01='''Reperfusion'''|B02='''Maintenance of RV preload'''|B03='''Decreased RV afterload'''|B04='''Restoring Rate/Rhythm and AV synchrony'''|B05='''Inotropic support'''|B06='''Mechanical Circulatory Support'''}} | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | |!| | | |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | |!| | | |}} | ||
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | | | {{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | |C06 | | | | ||
|C01=<div style="float: Center; text-align: left;"> •'''Thrmobolytics''' <br> •'''Percutaneous coronary intervention (PCI)''' <br> | |C01=<div style="float: Center; text-align: left;"> •'''Thrmobolytics''' <br> •'''Percutaneous coronary intervention (PCI)''' <br> | ||
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload reducing agents''', such as:<br> | |C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload reducing agents''', such as:<br> | ||
Line 30: | Line 30: | ||
:❑Direct RV support | :❑Direct RV support | ||
:❑Indirect RV support | :❑Indirect RV support | ||
:❑Biventricular support}} | :❑Biventricular support}}{{familytree/end}} | ||
{{familytree/end}} |
Revision as of 18:24, 3 August 2020
Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Thrmobolytics •Percutaneous coronary intervention (PCI) | • Avoidance of preload reducing agents, such as:
• In patients with hypotension (without pulmonary congestion):
| • Systemic or pulmonary vasodilators: | • In patients with bradyarrhthmias: • In patients with atrioventricular block:
| In patients with refractory hypotension:
| • May be needed in patients with cardiogenic shock secondary to RVMI:
| {{{ }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||